|
1
|
Boring CC, Squires TS and Tong TL: Cancer
statistics, 1992. CA Cancer J Clin. 42:19–38. 1992. View Article : Google Scholar
|
|
2
|
Sim HG and Cheng CW: Changing demography
of prostate cancer in Asia. Eur J Cancer. 41:834–845. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gozuacik D and Kimchi A: Autophagy as a
cell death and tumor suppressor mechanism. Oncogene. 23:2891–2906.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar
|
|
6
|
Mathew R, Kongara S, Beaudoin B, et al:
Autophagy suppresses tumor progression by limiting chromosomal
instability. Genes Dev. 21:1367–1381. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Klionsky DJ, Cregg JM, Dunn WA Jr, Emr SD,
Sakai Y, Sandoval IV, Sibirny A, Subramani S, Thumm M, Veenhuis M
and Ohsumi Y: A unified nomenclature for yeast autophagy-related
genes. Dev Cell. 5:539–545. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reggiori F and Klionsky DJ: Autophagy in
the eukaryotic cell. Eukaryot Cell. 1:11–21. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mizushima N, Yamamoto A, Hatano M,
Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y and Yoshimori
T: Dissection of autophagosome formation using Apg5-deficient mouse
embryonic stem cells. J Cell Biol. 152:657–668. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kihara A, Kabeya Y, Ohsumi Y and Yoshimori
T: Beclin-phosphatidylinositol 3-kinase complex functions at the
trans-Golgi network. EMBO Rep. 2:330–335. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li M, Jiang X, Liu D, et al: Autophagy
protects LNCaP cells under androgen deprivation conditions.
Autophagy. 4:54–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chhipa RR, Wu Y and Ip C: AMPK-mediated
autophagy is a survival mechanism in androgen-dependent prostate
cancer cells subjected to androgen deprivation and hypoxia. Cell
Signal. 23:1466–1472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ohuchida K, Mizumoto K, Ishikawa N, et al:
The role of S100A6 in pancreatic cancer development and its
clinical implication as a diagnostic marker and therapeutic target.
Clin Cancer Res. 11:7785–7793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aita VM, Liang XH, Murty W, et al: Cloning
and genomic organization of beclin 1, a candidate tumor suppressor
gene on chromosome 17q21. Genomics. 59:59–65. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lian J, Karnak D and Xu L: The
Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus
apoptosis in prostate cancer cells. Autophagy. 6:1201–1203. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roehrborn CG, Bruskewitz R, Nickel GC, et
al: Urinary retention in patients with BPH treated with finasteride
or placebo over 4 years. Characterization of patients and ultimate
outcomes. The PLESS Study Group. Eur Urol. 37:528–536. 2000.
|
|
19
|
Almond JB and Cohen GM: The proteasome: a
novel target for cancer chemotherapy. Leukemia. 16:433–443. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kok SH, Cheng SJ, Hong CY, et al:
Norcantharidin-induced apoptosis in oral cancer cells is associated
with an increase of proapoptotic to antiapoptotic protein ratio.
Cancer Lett. 217:43–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tullo A, D’Erchia AM and Sbisà E: Methods
for screening tumors for p53 status and therapeutic explication.
Expert Rev Mol Diagn. 3:289–301. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Faried A, Faried LS, Kato H, et al:
Targeting p53 tumor suppressor to induce apoptosis and cell cycle
arrest in esophageal cancer cells by novel sugar-cholesterol
compounds. Poster Session. 7:83–84. 2008.
|
|
23
|
Oka K, Nakano T and Arai T: p53CM1
expression is not associated with prognosis in uterine cervical
carcinoma. Cancer. 72:160–164. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei Y, Pattingre S and Levine B: Bcl-2
phosphorylation regulates its antiautophagy function. Monterey:
Keystone Symposium on Autophagy in Health and Disease; 2007
|
|
25
|
Pattingre S, Tassa A, Qu X, et al: Bcl-2
antiapopotic proteins inhibit Beclin 1-dependent autophagy. Cell.
122:927–939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu J, Xu Z, Jiang Y, et al: Cryptorchidism
induces mouse testicular germ cell apoptosis and changes in bcl-2
and bax protein expression. J Environ Pathol Toxicol Oncol.
19:25–33. 2000.PubMed/NCBI
|
|
27
|
Feng Z: P53 Regulation of the
IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring
Harb Perspect Biol. 2:a00010572010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Y, Chen SY, Ross KN and Balk SP:
Androgens induce prostate cancer cell proliferation through
mammalian target of rapamycin activation and post-transcriptional
increases in cyclin D proteins. Cancer Res. 66:7783–7792. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lan RZ, Ye ZQ, Yang WM, et al:
Microcirculation changes in the ventral prostates of rats after
castration. Natl J Androl. 11:119–123. 2005.(In Chinese).
|
|
30
|
Thompson IM, Goodman PJ, Tangen CM, et al:
The influence of finastefide on the development of prostate cancer.
N Engl J Med. 349:215–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kramer BS, Hagerty KL, Justman S, et al;
American Society of Clinical Oncology Health Services Committee;
American Urological Association Practice Guidelines Committee. Use
of 5-alpha-reductase inhibitors for prostate cancer
chemoprevention: American Society of Clinical Oncology/American
Urological Association 2008 Clinical Practice Guideline. J Clin
Oncol. 27:1502–1516. 2009. View Article : Google Scholar
|
|
32
|
Zhu J, Gao JP, Xu AX, et al: The influence
of benign prostatic hyperplasia drugs on incidence and pathology
grading of prostate cancer. Zhonghua Wai Ke Za Zhi. 48:761–763.
2010.(In Chinese).
|
|
33
|
Li J, Hou N, Faried A, et al: Inhibition
of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis
in colon cancer cells. Ann Surg Oncol. 16:761–771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Paglin S, Hollister T, Delohery T, et al:
A novel response of cancer cells to radiation involves autophagy
and formation of acidic vesicles. Cancer Res. 61:439–445.
2001.PubMed/NCBI
|
|
35
|
Kessel D, Reiners JJ Jr, Haseldine ST, et
al: The role of autophagy in the death of L1210 leukemia cells
initiated by the new antitumor agents, XK469 and SH80. Mol Cancer
Ther. 6:370–379. 2007. View Article : Google Scholar : PubMed/NCBI
|
